Vertex Pharmaceuticals (VRTX)

Change in Working Capital

-$668.50M

TTM · Period ending: · USD

VRTX logo

VRTX Change in Working Capital

Latest reported-$668.50M
VRTX TTM Change in Working Capital ($400.00K → -$668.50M)
High-resolution chart · PNG

VRTX change in working capital history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Change in Working Capital — Trailing twelve months (TTM) (USD)
Period endingChange in Working Capital (USD)
-668,500,000
-685,900,000
-1,199,100,000
-811,500,000
-803,600,000
-912,600,000
-514,800,000
-793,500,000
-762,100,000
-275,300,000
-265,700,000
482,300,000
374,200,000
512,500,000
340,800,000
566,384,000
394,019,000
-154,139,000
-105,200,000
-547,045,000
-359,608,000
-15,890,000
-54,454,000
30,691,000
69,861,000
-26,305,000
-66,101,000
239,100,000
184,140,000
162,497,000
238,020,000
188,729,000
105,910,000
94,260,000
15,264,000
23,341,000
59,147,000
-18,617,000
-2,070,000
-56,193,000
-116,898,000
-52,244,000
-85,950,000
-72,365,000
-26,376,000
-88,416,000
-11,063,000
-1,249,000
44,270,000
70,220,000
-5,051,000
3,565,000
17,330,000
26,678,000
-13,788,000
222,495,000
-169,098,000
-253,348,000
-193,064,000
-478,728,000
-160,869,000
-60,468,000
-63,777,000
-21,278,000
74,369,000
52,716,000
61,424,000
69,859,000
-50,295,000
113,978,000
138,783,000
129,186,000
172,479,000
23,161,000
47,300,000
39,943,000
161,371,000
141,061,000
123,054,000
128,640,000
-37,219,000
-58,093,000
-52,073,000
-52,138,000
-44,670,000
-9,719,000
-12,741,000
-16,694,000
32,268,000
55,911,000
68,944,000
73,518,000
45,770,000
5,352,000
867,000
29,112,000
19,730,000
29,982,000
41,090,000
-6,412,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.